Anatara Lifesciences (ASX:ANR) 3-Year EBITDA Growth Rate : 37.30% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences 3-Year EBITDA Growth Rate?

Anatara Lifesciences's EBITDA per Share for the six months ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 37.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 27.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Anatara Lifesciences was 37.30% per year. The lowest was -44.90% per year. And the median was 12.75% per year.

Competitive Comparison of Anatara Lifesciences's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Anatara Lifesciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anatara Lifesciences's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anatara Lifesciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Anatara Lifesciences's 3-Year EBITDA Growth Rate falls into.

Anatara Lifesciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Anatara Lifesciences (ASX:ANR) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Anatara Lifesciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines